Lungs News and Research

RSS

High-tech vest could be new way to prevent repeated trips to hospital for people with heart failure

Doctors at The Ohio State University Richard M. Ross Heart Hospital are testing a high-tech vest which measures fluid inside the lungs from outside a person's clothing. It could be a new way to prevent repeated trips to the hospital for the nearly six million Americans living with heart failure.

19 Jun 2017

Hidden immune cells play key role in driving primary graft dysfunction

Northwestern Medicine scientists have discovered that a subset of immune cells called nonclassical monocytes (NCMs), previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the leading cause of death after lung transplantation.

15 Jun 2017

New chemoprevention trial hopes to stop dangerous lesions from progressing to cancer

New treatments have extended the lives of many lung cancer patients. However, even better than treating lung cancer would be preventing it from developing in the first place.

15 Jun 2017

New tools can potentially play key role in early diagnosis of systemic sclerosis

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis.

14 Jun 2017

Cigarette smoking causes diverse harm that extends way beyond the lungs

Warning: Cigarette smoking presents far more health hazards than you probably realize.

14 Jun 2017

Antibody-based theranostic agent shows promise for identifying and treating pancreatic tumors

Pancreatic cancer is associated with bleak five-year survival rates and limited treatment options, but new research is offering hope.

13 Jun 2017

New discovery provides explanation for preterm infants' susceptibility to lung diseases later in life

Mice born into an oxygen-rich environment respond worse to the flu once fully grown due to an absence of certain lung cells, a discovery that provides a potential explanation for preterm infants' added susceptibility to influenza and other lung diseases later in their lives, according to new research from the University of Rochester Medical Center

9 Jun 2017

When an insurer balks and treatment stops

Gillen Washington, a student at Northern Arizona University, had been getting medication for an immunodeficiency disease since 2011. But when he went to his clinic in November 2014 for the monthly dose, a nurse told him his insurance company had denied it.

7 Jun 2017

Diabetes medication can protect against cardiac stiffening in obese female mice

Overconsumption of a Western diet high in fats and refined sugars has contributed to a global increase in obesity and Type 2 diabetes.

6 Jun 2017

Scientists discover mechanism that provides potential new target for allergy treatments

In news that may bring hope to asthma sufferers, scientists discover a mechanism that provides a possible new target for allergy treatments.

6 Jun 2017

Scientists receive $2.3 million NIH grant to uncover how omega-3 fatty acid stops lupus trigger

Michigan State University scientists have received a $2.3 million, five-year National Institutes of Health grant to help uncover why an omega-3 fatty acid, known as DHA, is so effective in stopping a known trigger of lupus.

2 Jun 2017

Cholesterol shown to have clear effect on lung surface properties

Cholesterol, a naturally occurring compound at the lung surface, has been shown to have a clear effect on the properties of this nanoscale film that covers the inside of our lungs.

1 Jun 2017

Patients who undergo Fontan surgery for congenital heart defect have liver fibrosis risk, study reveals

Patients who undergo the Fontan operation as children for a complex congenital heart defect are at risk of developing progressive liver fibrosis, a buildup of fibrous deposits, as a result of the circulation created by the surgery, according to a new study.

31 May 2017

FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application for SUN-101/eFlow (glycopyrrolate) for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema

27 May 2017

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.

27 May 2017

Particulate matter from diesel vehicles linked to heart damage

Diesel pollution is linked with heart damage, according to research presented today at EuroCMR 2017.

26 May 2017

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.

25 May 2017

Zephyr Endobronchial Valves demonstrate clinical efficacy in heterogeneous and homogenous emphysema patients

Pulmonx, Inc. today announced the results of two multi-center, randomized clinical trials showing clinically meaningful improvements in lung function after treatment with the Zephyr Endobronchial Valve (EBV) in emphysema patients without collateral ventilation.